KRAS/NRAS Test sale cost 3600 AED
Nx Gen Sequencing Canavan Disease Test sale cost 4680 AED Nx Gen Sequencing Canavan Disease Test Cost 5,200 د.إ Original price was: 5,200 د.إ.4,680 د.إCurrent price is: 4,680 د.إ.
Thalassemia Beta Trio Prenatal Mutation Detection Test sale cost 4210 AED Thalassemia Beta Trio Prenatal Mutation Detection Test Cost 4,680 د.إ Original price was: 4,680 د.إ.4,210 د.إCurrent price is: 4,210 د.إ.
Sale!

KRAS/NRAS Test Cost

Original price was: 4,800 د.إ.Current price is: 3,600 د.إ.

-25%

The KRAS/NRAS test is a specialized diagnostic procedure designed to identify mutations in the KRAS and NRAS genes, which are known to play a significant role in the development and progression of certain types of cancers, including colorectal and lung cancers. This test is crucial for determining the most effective treatment plan for patients, as the presence of mutations can influence the response to targeted therapies.

Performed at DNA Labs UAE, a leading facility in genetic testing, the KRAS/NRAS test utilizes advanced molecular techniques to accurately detect these genetic alterations. The cost of the test is set at 3600 AED, reflecting the comprehensive analysis and the technical expertise required to interpret the results.

By identifying specific mutations in the KRAS and NRAS genes, healthcare providers can tailor cancer treatment to the individual patient, improving outcomes and minimizing unnecessary treatments. This test represents a significant step forward in the field of personalized medicine, offering hope for more effective and targeted cancer therapies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KRASNRAS Test Cost AED: 3600.0

At DNA Labs UAE, we offer the KRASNRAS Test at a cost of AED 3600.0. This test is used to diagnose and detect mutations in the KRAS and NRAS genes, which are commonly mutated in various types of cancer.

Test Details

The KRAS and NRAS genes encode proteins involved in cell signaling pathways. When these genes are mutated, they can lead to the continuous activation of the signaling pathways, promoting cell growth, proliferation, and survival. This can contribute to the development and progression of cancer.

Testing for KRAS and NRAS mutations in cancer cells is crucial for treatment decisions. Certain targeted therapies, such as EGFR inhibitors, may be less effective in patients with KRAS or NRAS mutations. Therefore, identifying these mutations can help guide treatment options and prognosis.

Test Components

The KRASNRAS Test requires paraffin embedded tissue blocks as a sample condition. These tissue blocks are used to extract the necessary genetic material for analysis.

Price and Report Delivery

The cost of the KRASNRAS Test is AED 3600.0. The report delivery time is estimated to be 7-8 days.

Method and Test Type

The KRASNRAS Test is performed using Sanger Sequencing, a widely used method for DNA sequencing. This test falls under the category of Genetics.

Referring Doctor and Test Department

The referring doctor for the KRASNRAS Test is a Gynecologist. The test is conducted in the Test Department.

Pre Test Information

The KRASNRAS Test requires a doctor’s prescription. However, the prescription is not applicable for surgery and pregnancy cases, as well as individuals planning to travel abroad.

At DNA Labs UAE, we understand the importance of genetic testing in cancer diagnosis and treatment. Our KRASNRAS Test can provide valuable insights into the presence of mutations in the KRAS and NRAS genes, helping healthcare professionals make informed decisions for their patients.

Test Name KRASNRAS Test
Components Paraffin embedded tissue blocks
Price 3600.0 AED
Sample Condition Tumor tissue
Report Delivery 7-8 days
Method Sanger Sequencing
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information KRAS,NRAS can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

KRAS and NRAS are genes that encode proteins involved in cell signaling pathways. They are commonly mutated in various types of cancer, including colorectal, lung, and pancreatic cancers.

KRAS and NRAS mutations are usually activating mutations, meaning that they lead to the continuous activation of the signaling pathways they are involved in. This continuous activation promotes cell growth, proliferation, and survival, contributing to the development and progression of cancer.

The presence of KRAS or NRAS mutations in cancer cells can have implications for treatment options and prognosis. For example, certain targeted therapies, such as EGFR inhibitors, may be less effective in patients with KRAS or NRAS mutations. Therefore, it is important to test for these mutations in cancer patients to guide treatment decisions.

SKU: TEST-4649 Category:

Related products